Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $359.0400 (-1.32%) ($359.0400 - $359.0400) on Wed. Jan. 22, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.72% (three month average) | RSI | 41 | Latest Price | $359.0400(-1.32%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN declines -1.5% a day on average for past five trading days. | Weekly Trend | REGN advances 0.4% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(58%) XLV(47%) IVW(41%) IWF(40%) QQQ(40%) | Factors Impacting REGN price | REGN will decline at least -0.86% in a week (0% probabilities). VIXM(-23%) VXX(-10%) TLT(-5%) IGOV(-5%) TIP(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.86% (StdDev 1.72%) | Hourly BBV | -1.1 () | Intraday Trend | 0% | | | |
|
Resistance Level | $376.84 | 5 Day Moving Average | $377.04(-4.77%) | 10 Day Moving Average | $379.65(-5.43%) | 20 Day Moving Average | $376.84(-4.72%) | To recent high | -8.2% | To recent low | 19.2% | Market Cap | $38.069b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |